Results: Associations between BC and blood markers were not observed in main effects models or when stratified by obesity status.
The HR estimates did not change significantly when BMI, use of hormone therapy, or smoking status were added to the model, nor when stratified by BMI (<25 or ≥25 kg/m) (data not shown).
Finally, we examined the model's accuracy when stratified by vital status at ICU discharge.
Finally, in terms of examining increases in antigenemia stratified by type of RDT, regrettably, the small sample size particularly in the BCG-negative, malaria-positive cells (2x2 table) led to problems in model convergence when stratifying results by diagnostic used.
The addition of mean room temperature into the random-effects model did not affect the relationship between α and age, even when stratified by age group.
Figure S2 is a representation of this regression model showing that renal length is inversely proportional to cystatin C when stratified by height.
When stratified for the source of controls, significant heterogeneity still existed in some genetic models for the population-based studies.
When stratified by disease severity using the Acute Physiology and Chronic Health Evaluation III model, however, the crude mortality differences were less striking, with no statistical differences observed.
When stratified by dominant ethnicity, no significant relevance was observed in both Caucasians (random-effects model: pooled HR = 1.05; 95% CI: 0.51 2.17; P = 0.887) and Asians (random-effects model: pooled HR = 1.49; 95% CI: 0.48 4.66; P = 0.493)).
The FCGR3A genotypes were not associated with response to cetuximab when stratified for BRAF or KRAS mutational status, Table 5. *Logistic regression, †Cox proportional hazard model.
